IGI Logo

Global Landscape: COVID-19 Vaccine Candidates in Clinical Trials

NEGVAC (National Expert Group on Vaccine Administration for COVID-19)

* Constituted on 7 th August 2020, Member (Health) NITI Aayog is chair and Secretary, H&FW is Co-chair * Representation of:

* Relevant ministries of Government of India

* Five State governments viz. Assam, Madhya Pradesh, Maharashtra, Tamil Nadu and Uttar Pradesh

* Technical Experts

* NEGVAC provides guidance on:

* Prioritization of population groups

* Procurement and Inventory management

* Vaccine selection and

* Vaccine delivery and tracking mechanism

Key Considerations During COVID-19 Vaccination Planning

* The COVID-19 vaccination strategy has been formulated as per guidance of NEGVAC.

* Most candidate vaccines follow a 2-dose schedule. - One and three dose schedule for one candidate vaccine each.

* Vaccines are developed using multiple platforms, they are not interchangeable.

* A beneficiary MUST complete vaccination schedule using same vaccine product.

* Storage temperature for most candidate vaccines similar to other UIP vaccines (2⁰ to 8⁰ C)

* Roll-out of vaccine should be done following the election model.

To Read Complete Report & Disclaimer Click Here

Above views are of the author and not of the website kindly read disclaimer